<code id='3D049DB867'></code><style id='3D049DB867'></style>
    • <acronym id='3D049DB867'></acronym>
      <center id='3D049DB867'><center id='3D049DB867'><tfoot id='3D049DB867'></tfoot></center><abbr id='3D049DB867'><dir id='3D049DB867'><tfoot id='3D049DB867'></tfoot><noframes id='3D049DB867'>

    • <optgroup id='3D049DB867'><strike id='3D049DB867'><sup id='3D049DB867'></sup></strike><code id='3D049DB867'></code></optgroup>
        1. <b id='3D049DB867'><label id='3D049DB867'><select id='3D049DB867'><dt id='3D049DB867'><span id='3D049DB867'></span></dt></select></label></b><u id='3D049DB867'></u>
          <i id='3D049DB867'><strike id='3D049DB867'><tt id='3D049DB867'><pre id='3D049DB867'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:931
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug
          In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

          DarronCummings/APInasurprisemove,theFoodandDrugAdministrationhascalledforameetingofoutsideadvisersto

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Medicare drug price negotiation program allowed for now

          AfederaljudgemadeakeyrulinginalawsuitchallenginganewdrugpricingprogramAdobeWASHINGTON—Afederalcourtj